{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T19:32:46Z","timestamp":1783366366064,"version":"3.54.6"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Genom"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s13258-019-00836-4","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T16:15:30Z","timestamp":1559664930000},"page":"1045-1053","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Human epididymis protein 4 (HE4) protects against cystic pulmonary fibrosis associated-inflammation through inhibition of NF-\u03baB and MAPK singnaling"],"prefix":"10.1007","volume":"41","author":[{"given":"Jinli","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenfen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piaopiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,4]]},"reference":[{"key":"836_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1365-2796.2006.01744.x","volume":"261","author":"R Boucher","year":"2007","unstructured":"Boucher R (2007) Evidence for airway surface dehydration as the initiating event in CF airway disease. J Intern Med 261:5\u201316","journal-title":"J Intern Med"},{"key":"836_CR2","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1080\/17512433.2017.1378094","volume":"10","author":"M Bulloch","year":"2017","unstructured":"Bulloch M, Hanna C, Giovane R (2017) Lumacaftor\/ivacaftor, a novel agent for the treatment of cystic fibrosis patients who are homozygous for the F580del CFTR mutation. Expert Rev Clin Pharmacol 10:1055\u20131072","journal-title":"Expert Rev Clin Pharmacol"},{"key":"836_CR3","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3343\/alm.2017.37.6.526","volume":"37","author":"S Choi","year":"2017","unstructured":"Choi S, Jang M, Jeon B, Shin H, Lee Y, Lee Y (2017) Clinical usefulness of human epididymis protein 4 in lung cancer. Ann Lab Med 37:526\u2013530","journal-title":"Ann Lab Med"},{"key":"836_CR4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4103\/1008-682X.155769","volume":"17","author":"V Da Ros","year":"2015","unstructured":"Da Ros V, Mu\u00f1oz M, Battistone M, Brukman N, Carvajal G, Curci L, G\u00f3mez-ElIas M, Cohen D, Cuasnicu P (2015) From the epididymis to the egg: participation of CRISP proteins in mammalian fertilization. Asian J Androl 17:711\u2013715","journal-title":"Asian J Androl"},{"key":"836_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13046-015-0208-8","volume":"34","author":"L Deng","year":"2015","unstructured":"Deng L, Gao Y, Li X, Cai M, Wang H, Zhuang H, Tan M, Liu S, Hao Y, Lin B (2015) Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma. J Exp Clin Cancer Res 34:96","journal-title":"J Exp Clin Cancer Res"},{"key":"836_CR6","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","volume":"388","author":"J Elborn","year":"2016","unstructured":"Elborn J (2016) Cystic fibrosis. Lancet 388:2519\u20132531","journal-title":"Lancet"},{"key":"836_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/jclinpath-2012-201031","volume":"66","author":"S Ferraro","year":"2013","unstructured":"Ferraro S, Braga F, Lanzoni M, Boracchi P, Biganzoli E, Panteghini M (2013) Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review. J Clin Pathol 66:273\u2013281","journal-title":"J Clin Pathol"},{"issue":"2","key":"836_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10787-017-0329-0","volume":"26","author":"ME Franca","year":"2017","unstructured":"Franca ME, Rocha SW, Oliveira WH, Santos LA, de Oliveira AG, Barbosa KP, Nunes AK, Rodrigues GB, Los DB, Peixoto CA (2017) Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis. Inflammopharmacology 26(2):599\u2013609","journal-title":"Inflammopharmacology"},{"key":"836_CR9","doi-asserted-by":"crossref","unstructured":"Graeber SY, Dopfer C, Naehrlich L, Gyulumyan L, Scheuermann H, Hirtz S, Wege S, Mairbaurl H, Dorda M, Hyde R et al. (2018) Effects of Lumacaftor\/ivacaftor therapy on CFTR function in Phe508del homozygous patients with cystic fibrosis. Am J Respir Crit Care Med","DOI":"10.1183\/13993003.congress-2018.PA3415"},{"key":"836_CR10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/vop.12331","volume":"19","author":"K Gronkiewicz","year":"2016","unstructured":"Gronkiewicz K, Giuliano E, Sharma A, Mohan R (2016) Molecular mechanisms of suberoylanilide hydroxamic acid in the inhibition of TGF-\u03b21-mediated canine corneal fibrosis. Vet Ophthalmol 19:480\u2013487","journal-title":"Vet Ophthalmol"},{"issue":"3","key":"836_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jcf.2017.11.013","volume":"17","author":"A Jackson","year":"2017","unstructured":"Jackson A, Goss C (2017) Epidemiology of CF: How registries can be used to advance our understanding of the CF population. J Cyst Fibros 17(3):297\u2013305","journal-title":"J Cyst Fibros"},{"key":"836_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.lfs.2017.07.004","volume":"184","author":"YH Kao","year":"2017","unstructured":"Kao YH, Chen PH, Wu TY, Lin YC, Tsai MS, Lee PH, Tai TS, Chang HR, Sun CK (2017) Lipopolysaccharides induce Smad2 phosphorylation through PI3K\/Akt and MAPK cascades in HSC-T6 hepatic stellate cells. Life Sci 184:37\u201346","journal-title":"Life Sci"},{"key":"836_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/ng1194-216a","volume":"8","author":"N Kaplan","year":"1994","unstructured":"Kaplan N, Lewis P, Weir B (1994) Age of the delta F508 cystic fibrosis mutation. Nat Genet 8:216\u2013218","journal-title":"Nat Genet"},{"key":"836_CR14","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1158\/1055-9965.EPI-14-0447","volume":"23","author":"N Karlsen","year":"2014","unstructured":"Karlsen N, Karlsen M, H\u00f8gdall C, H\u00f8gdall E (2014) HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review. Cancer Epidemiol Biomarkers Prev 23:2285\u20132295","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"836_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3892\/mco.2017.1332","volume":"7","author":"Y Kemal","year":"2017","unstructured":"Kemal Y, Demirag G, Bedir A, Tomak L, Derebey M, Erdem D, G\u00f6r U, Y\u00fccel I (2017) Serum human epididymis protein 4 levels in colorectal cancer patients. Mol Clin Oncol 7:481\u2013485","journal-title":"Mol Clin Oncol"},{"key":"836_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S2213-2600(14)70100-6","volume":"2","author":"E Kerem","year":"2014","unstructured":"Kerem E, Konstan M, De Boeck K, Accurso F, Sermet-Gaudelus I, Wilschanski M, Elborn J, Melotti P, Bronsveld I, Fajac I et al (2014) Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Respir Med 2:539\u2013547","journal-title":"Lancet Respir Med"},{"key":"836_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/14728222.2018.1406922","volume":"22","author":"EL Kramer","year":"2018","unstructured":"Kramer EL, Clancy JP (2018) TGFbeta as a therapeutic target in cystic fibrosis. Expert Opin Ther Targets 22:177\u2013189","journal-title":"Expert Opin Ther Targets"},{"key":"836_CR18","first-page":"88","volume":"23","author":"L Kulczycki","year":"1991","unstructured":"Kulczycki L (1991) Five decades of cystic fibrosis (1938\u20131988). Mater Med Pol 23:88\u201391","journal-title":"Mater Med Pol"},{"key":"836_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nm.2989","volume":"19","author":"V LeBleu","year":"2013","unstructured":"LeBleu V, Teng Y, O\u2019Connell J, Charytan D, M\u00fcller G, M\u00fcller C, Sugimoto H, Kalluri R (2013) Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med 19:227\u2013231","journal-title":"Nat Med"},{"key":"836_CR20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/ncb2090","volume":"12","author":"A Luciani","year":"2010","unstructured":"Luciani A, Villella V, Esposito S, Brunetti-Pierri N, Medina D, Settembre C, Gavina M, Pulze L, Giardino I, Pettoello-Mantovani M et al (2010) Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat Cell Biol 12:863\u2013875","journal-title":"Nat Cell Biol"},{"key":"836_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-387042-1.00001-0","volume":"55","author":"M Montagnana","year":"2011","unstructured":"Montagnana M, Danese E, Giudici S, Franchi M, Guidi G, Plebani M, Lippi G (2011) HE4 in ovarian cancer: from discovery to clinical application. Adv Clin Chem 55:1\u201320","journal-title":"Adv Clin Chem"},{"key":"836_CR22","doi-asserted-by":"publisher","first-page":"1600903","DOI":"10.1183\/13993003.00903-2016","volume":"49","author":"ST Montgomery","year":"2017","unstructured":"Montgomery ST, Mall MA, Kicic A, Stick SM, Arest CF (2017) Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies. Eur Respir J 49:1600903","journal-title":"Eur Respir J"},{"key":"836_CR23","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.chest.2016.04.006","volume":"150","author":"B Nagy","year":"2016","unstructured":"Nagy B, Nagy B, Fila L, Clarke L, G\u00f6nczy F, Bede O, Nagy D, \u00dajhelyi R, Szab\u00f3 \u00c1, Anghelyi A et al (2016) Human epididymis protein 4: a novel serum inflammatory biomarker in cystic\u00a0fibrosis. Chest 150:661\u2013672","journal-title":"Chest"},{"issue":"Suppl 40","key":"836_CR24","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1002\/ppul.23242","volume":"50","author":"DP Nichols","year":"2015","unstructured":"Nichols DP, Chmiel JF (2015) Inflammation and its genesis in cystic fibrosis. Pediatr Pulmonol 50(Suppl 40):S39\u2013S56","journal-title":"Pediatr Pulmonol"},{"key":"836_CR25","doi-asserted-by":"publisher","first-page":"i859","DOI":"10.1136\/bmj.i859","volume":"352","author":"B Quon","year":"2016","unstructured":"Quon B, Rowe S (2016) New and emerging targeted therapies for cystic fibrosis. BMJ 352:i859","journal-title":"BMJ"},{"key":"836_CR26","first-page":"CD002768","volume":"11","author":"T Radtke","year":"2017","unstructured":"Radtke T, Nevitt S, Hebestreit H, Kriemler S (2017) Physical exercise training for cystic fibrosis. Cochrane Database Syst Rev 11:CD002768","journal-title":"Cochrane Database Syst Rev"},{"key":"836_CR27","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/nm1207-1417","volume":"13","author":"I Sabroe","year":"2007","unstructured":"Sabroe I, Whyte M (2007) Incapacitating the immune system in cystic fibrosis. Nat Med 13:1417\u20131418","journal-title":"Nat Med"},{"key":"836_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00011-017-1123-6","volume":"67","author":"A Santoro","year":"2017","unstructured":"Santoro A, Ciaglia E, Nicolin V, Pescatore A, Prota L, Capunzo M, Ursini MV, Nori SL, Bifulco M (2017) The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFkappaB and STAT3 pathways in cystic fibrosis cells. Inflamm Res 67:315\u2013326","journal-title":"Inflamm Res"},{"key":"836_CR29","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1126\/science.aad5589","volume":"351","author":"V Shah","year":"2016","unstructured":"Shah V, Meyerholz D, Tang X, Reznikov L, Abou Alaiwa M, Ernst S, Karp P, Wohlford-Lenane C, Heilmann K, Leidinger M et al (2016) Airway acidification initiates host defense abnormalities in cystic fibrosis mice. Science 351:503\u2013507","journal-title":"Science"},{"key":"836_CR30","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1172\/JCI83922","volume":"126","author":"X Tang","year":"2016","unstructured":"Tang X, Ostedgaard L, Hoegger M, Moninger T, Karp P, McMenimen J, Choudhury B, Varki A, Stoltz D, Welsh M (2016) Acidic pH increases airway surface liquid viscosity in cystic fibrosis. J Clin Invest 126:879\u2013891","journal-title":"J Clin Invest"},{"key":"836_CR31","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nm1748","volume":"14","author":"V Teichgr\u00e4ber","year":"2008","unstructured":"Teichgr\u00e4ber V, Ulrich M, Endlich N, Riethm\u00fcller J, Wilker B, De Oliveira-Munding C, van Heeckeren A, Barr M, von K\u00fcrthy G, Schmid K et al (2008) Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 14:382\u2013391","journal-title":"Nat Med"},{"key":"836_CR32","doi-asserted-by":"crossref","first-page":"67748","DOI":"10.18632\/oncotarget.11682","volume":"7","author":"J Wan","year":"2016","unstructured":"Wan J, Wang Y, Cai G, Liang J, Yue C, Wang F, Song J, Wang J, Liu M, Luo J et al (2016) Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease. Oncotarget 7:67748\u201367759","journal-title":"Oncotarget"},{"key":"836_CR33","first-page":"CD009528","volume":"10","author":"V Waters","year":"2017","unstructured":"Waters V, Ratjen F (2017) Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Cochrane Database Syst Rev 10:CD009528","journal-title":"Cochrane Database Syst Rev"},{"key":"836_CR34","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/ppul.23744","volume":"52","author":"J Xu","year":"2017","unstructured":"Xu J, Yin Y, Zhang L, Zhang J, Yuan S, Zhang H (2017) Four case reports of Chinese cystic fibrosis patients and literature review. Pediatr Pulmonol 52:1020\u20131028","journal-title":"Pediatr Pulmonol"},{"key":"836_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/1476-4598-13-243","volume":"13","author":"H Zhuang","year":"2014","unstructured":"Zhuang H, Tan M, Liu J, Hu Z, Liu D, Gao J, Zhu L, Lin B (2014) Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells. Mol Cancer 13:243","journal-title":"Mol Cancer"}],"container-title":["Genes & Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-019-00836-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13258-019-00836-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-019-00836-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T05:39:45Z","timestamp":1694929185000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13258-019-00836-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,4]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["836"],"URL":"https:\/\/doi.org\/10.1007\/s13258-019-00836-4","relation":{},"ISSN":["1976-9571","2092-9293"],"issn-type":[{"value":"1976-9571","type":"print"},{"value":"2092-9293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,4]]},"assertion":[{"value":"3 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Jinli Wang, Hongyang Zhao, Fenfen Xu, Piaopiao Zhang, Yuan Zheng and Nan Jia declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study had been approved by the ethics committee of the second Affiliated Hospital of Harbin Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}